These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 16312339

  • 1. Interactions between 4-quinolone antibacterials and multivalent metal ions.
    Smith JT.
    J Chemother; 1989 Jul; 1(4 Suppl):134-5. PubMed ID: 16312339
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Synthesis and antibacterial activity of N-[2-(5-bromothiophen-2-yl)-2-oxoethyl] and N-[(2-5-bromothiophen-2-yl)-2-oximinoethyl] derivatives of piperazinyl quinolones.
    Foroumadi A, Emami S, Mehni M, Moshafi MH, Shafiee A.
    Bioorg Med Chem Lett; 2005 Oct 15; 15(20):4536-9. PubMed ID: 16115766
    [Abstract] [Full Text] [Related]

  • 4. Conformationally constrained analogs of N-substituted piperazinylquinolones: synthesis and antibacterial activity of N-(2,3-dihydro-4-hydroxyimino-4H-1-benzopyran-3-yl)-piperazinylquinolones.
    Emami S, Foroumadi A, Samadi N, Faramarzi MA, Rajabalian S.
    Arch Pharm (Weinheim); 2009 Jul 15; 342(7):405-11. PubMed ID: 19544301
    [Abstract] [Full Text] [Related]

  • 5. Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents.
    Mitscher LA.
    Chem Rev; 2005 Feb 15; 105(2):559-92. PubMed ID: 15700957
    [No Abstract] [Full Text] [Related]

  • 6. "In vitro" study of sulfimidazole, trimethoprim and fluoroquinolones in traveller's bowel infections.
    Castelli M, Baggio G, Ruberto AI, Provvisionato A, Malagoli M, Bossa R, Galatulas I.
    G Ital Chemioter; 1991 Feb 15; 38(1-3):105-6. PubMed ID: 1365554
    [No Abstract] [Full Text] [Related]

  • 7. T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.
    Schmid DA, Depta JP, Pichler WJ.
    Clin Exp Allergy; 2006 Jan 15; 36(1):59-69. PubMed ID: 16393267
    [Abstract] [Full Text] [Related]

  • 8. 5-Hydroxymethyl-oxazolidin-2-one antibacterials. Actelion Pharmaceuticals: WO2008062379.
    Phillips OA, Sharaf LH.
    Expert Opin Ther Pat; 2009 Apr 15; 19(4):529-40. PubMed ID: 19441931
    [Abstract] [Full Text] [Related]

  • 9. Plasmid determined resistance to quinolones in clinical isolates of Gram-negative bacilli.
    Diani OA, Ogbolu DO, Ogunledun A.
    Afr J Med Med Sci; 2006 Dec 15; 35(4):437-41. PubMed ID: 17722809
    [Abstract] [Full Text] [Related]

  • 10. Mannich bases of 7-piperazinylquinolones and kojic acid derivatives: synthesis, in vitro antibacterial activity and in silico study.
    Emami S, Ghafouri E, Faramarzi MA, Samadi N, Irannejad H, Foroumadi A.
    Eur J Med Chem; 2013 Oct 15; 68():185-91. PubMed ID: 23974018
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of the new quinolones: an overview.
    Garcia-Rodriguez JA.
    J Chemother; 1989 Jul 15; 1(4 Suppl):136-8. PubMed ID: 16312340
    [No Abstract] [Full Text] [Related]

  • 12. Clinical impact of in vitro data with newer quinolones.
    Smith JT.
    J Chemother; 1989 Jul 15; 1(4 Suppl):662-3. PubMed ID: 16312581
    [No Abstract] [Full Text] [Related]

  • 13. Concept, design, and preclinical evaluation of quinolonyl lactam antibacterials.
    Hershberger PM, Demuth TP.
    Adv Exp Med Biol; 1998 Jul 15; 456():239-67. PubMed ID: 10549372
    [No Abstract] [Full Text] [Related]

  • 14. Novel antibacterial active quinolone-fluoroquinolone conjugates and 2D-QSAR studies.
    Panda SS, Liaqat S, Girgis AS, Samir A, Hall CD, Katritzky AR.
    Bioorg Med Chem Lett; 2015 Sep 15; 25(18):3816-21. PubMed ID: 26253630
    [Abstract] [Full Text] [Related]

  • 15. Synergy studies of ciprofloxacin and other quinolone derivatives in combination with further antibiotics.
    Höffler U.
    Chemioterapia; 1987 Jun 15; 6(2 Suppl):140-2. PubMed ID: 2855612
    [No Abstract] [Full Text] [Related]

  • 16. Determination of the postantibiotic effect of ofloxacin on gram-negative bacteria utilizing a new method.
    Nilsson L, Isaksson B, Maller R, Nilsson M.
    J Chemother; 1989 Jul 15; 1(4 Suppl):149-51. PubMed ID: 16312347
    [No Abstract] [Full Text] [Related]

  • 17. Synthesis and antibacterial activity of 7-(1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-7-yl) quinolones.
    Zhu B, Marinelli BA, Goldschmidt R, Foleno BD, Hilliard JJ, Bush K, Macielag MJ.
    Bioorg Med Chem Lett; 2009 Sep 01; 19(17):4933-6. PubMed ID: 19646867
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the antibacterial activity of lomefloxacin with that of other antibiotic/chemotherapeutic agents.
    Cuffini AM, Tullio V, Vaiani G, Carlone NA.
    J Chemother; 1989 Jul 01; 1(4 Suppl):178-81. PubMed ID: 16312358
    [No Abstract] [Full Text] [Related]

  • 19. Preliminary results on the antibacterial and killing activity of lomefloxacin.
    Stefani S, Pellegrino MB, Mezzatesta M, Speciale AM, Caccamo F, Russo G, Nicoletti G.
    J Chemother; 1989 Jul 01; 1(4 Suppl):170-2. PubMed ID: 16312355
    [No Abstract] [Full Text] [Related]

  • 20. Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl)piperazine moiety.
    Foroumadi A, Ghodsi S, Emami S, Najjari S, Samadi N, Faramarzi MA, Beikmohammadi L, Shirazi FH, Shafiee A.
    Bioorg Med Chem Lett; 2006 Jul 01; 16(13):3499-503. PubMed ID: 16644219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.